Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Min Seok Kang is a pioneering head and neck surgeon whose work centers on advancing robotic surgery for complex aerodigestive tract and salivary gland tumors. His most impactful contribution is leading the first human trial of transoral robotic surgery (TORS) using a single-port robotic system for laryngo-pharyngeal cancer (42 citations), demonstrating a paradigm shift toward minimally invasive organ preservation. Dr. Kang has also systematically compared robotic versus conventional approaches for parapharyngeal space tumors (28 citations), proving superior functional outcomes with reduced morbidity. His refinement of retroauricular robotic parotidectomy (17 citations) established a scarless, precision technique for both benign and malignant parotid tumors, while his analysis of p16+ oropharyngeal cancer (12 citations) challenged prognostic assumptions in surgically treated patients. Notably, Dr. Kang’s comprehensive experience—documented in a landmark series of 945 robotic head and neck cases (2020)—validates the safety and scalability of these techniques. His work has redefined surgical standards for hypopharyngeal and advanced-stage cancers, offering patients reduced recovery times and improved quality of life. With cumulative citations exceeding 100, Dr. Kang is recognized as a global leader in robotic head and neck oncology, shaping the future of precision surgery.